Quick pharma delivery startup Plazza raises $15M Series A to scale store network

Bengaluru-based Plazza plans 10 stores in 8 weeks, 20 by year-end, and 3,000+ nationally within 3-4 years, competing with Tata 1mg, Apollo 24/7, Truemeds and PlatinumRx in quick medicine delivery.

— Source publishedMon, 20 Jul, 2026, 05:00 IST·First seen Mon, 20 Jul, 2026, 05:05 IST·Source Mint

What happened

Quick medicine delivery startup Plazza raises $15M Series A to expand store network in Bengaluru, targeting 3,000+ stores nationally within three to four years.

Key facts

  • $15 million Series A
  • 20 stores by end of year
  • 10 stores in next 8 weeks
  • 3,000+ stores in 3-4 years
  • 40,000 SKUs
  • 27x GMV growth June 2025-March 2026

Why this matters

Plazza's rapid scale-up plans make it a notable consolidation target or partnership prospect for larger pharmacy and quick-commerce players looking to expand delivery infrastructure quickly.

What to watch

  • Series B or bridge round announcement within 6-9 months
  • Competitor store count or funding disclosures matching Plazza's pace
  • State drug authority notices or license suspensions in target cities
  • Reported delivery-time or discount escalation among quick-pharma apps
  • Store closures or slowdown versus stated 20-by-year-end target
  • Track Plazza's actual store openings vs 10-in-8-weeks and 20-by-year-end targets
  • Watch for matching expansion or funding announcements from Tata 1mg, Apollo 24/7, Truemeds, PlatinumRx
  • Monitor city-level dark-store density and delivery-time claims (10-min benchmarks) for margin signals
  • Flag any drug-license or compliance actions against quick-commerce pharmacy operators
  • Assess Plazza's cash runway relative to store rollout capex/opex burn rate

Also reported by